Axogen (ELN) Announces Alliance with Stryker Orthopaedics to Bring AVANCE Nerve Grafts to More Patients Suffering from Peripheral Nerve Injuries
1/24/2008 11:51:26 AM
ALACHUA, Fla.--(BUSINESS WIRE)--AxoGen, Inc. announces an exclusive agreement with Stryker Orthopaedics to provide distribution and co-marketing services for the new AVANCE Nerve Graft. Stryker will be responsible for AVANCE Nerve Graft distribution services for nerve repairs in the upper extremities, lower extremities and brachial plexus. AxoGen will provide distribution services within the head, neck and torso. AVANCE Nerve Graft is intended for use in the repair of damaged and diseased peripheral nerves. AVANCE Nerve Graft is the only product currently available that gives surgeons the option to repair damaged peripheral nerves with human allograft nerve while eliminating a second donor site surgery.
comments powered by